After adjusting for sex, age, BMI, hyperlipidemia, hypertension, diabetes, brain metastases, and radiotherapy, the EGFR‐TKI group had an almost 2.78‐fold higher relative risk of increased WMH load compared to non‐EGFR‐TKI. This evidence concerns the gene EGFR and diabetes mellitus.